These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29056320)

  • 1. Effective use of human papillomavirus testing for cervical cancer screening requires extended intervals to target persistent infections and precancerous lesions.
    Schiffman M; Wentzensen N
    Prev Med; 2017 Dec; 105():378-380. PubMed ID: 29056320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale for implementation of HPV testing in routine cervical screening in Romania.
    Iancu LS; Ursu RG
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Franco EL;
    Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
    [No Abstract]   [Full Text] [Related]  

  • 5. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV Testing Bests Pap for Cervical Screening.
    Cancer Discov; 2018 Sep; 8(9):OF6. PubMed ID: 30054288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of cervical cancer in Latin America.
    Bosch FX
    Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
    [No Abstract]   [Full Text] [Related]  

  • 9. Rethinking cervical cancer screening.
    Niekerk DV; Ogilvie G; Miller D
    J Obstet Gynaecol Can; 2012 May; 34(5):411-412. PubMed ID: 22555131
    [No Abstract]   [Full Text] [Related]  

  • 10. HPV testing and vaccination in Europe.
    Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
    J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
    Poljak M; Ginocchio CC
    J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of cervical precancers: a global perspective.
    Echelman D; Feldman S
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research.
    Desai KT; de Sanjosé S; Schiffman M
    Cancer Prev Res (Phila); 2023 Dec; 16(12):649-651. PubMed ID: 38037384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
    Feticu L; Bocşan IS; Bondor Cl; Boboş C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
    Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
    Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing cervical cancer screening in women infected with HIV: a review of the literature.
    Chapman Lambert CL
    J Assoc Nurses AIDS Care; 2013; 24(3):189-97. PubMed ID: 22999769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.